PST: Periosteal Stimulation for Knee Osteoarthritis

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00865046
Collaborator
(none)
190
1
3
46
4.1

Study Details

Study Description

Brief Summary

185 veterans with chronic knee pain and advanced knee osteoarthritis will be recruited to participate in this study designed to test the effectiveness of a special type of electrical acupuncture called periosteal stimulation (PST). Participants will be divided into three groups. They will receive PST or a control condition once a week for 10 weeks. Two-thirds of the participants will receive booster sessions periodically over the course of the next 6 months. Everyone will be called monthly during the 6 month period and then will be asked to return for an evaluation on site at the end of this period.

Condition or Disease Intervention/Treatment Phase
  • Other: Periosteal stimulation
  • Other: Control-Periosteal Stimulation
N/A

Detailed Description

We have performed a promising initial trial of periosteal stimulation (PST, that is, electrical stimulation of 4 acupuncture needles around the knee that touch periosteum) as an analgesic for older veterans with advanced knee osteoarthritis (OA) and daily pain. The primary aim of the proposed trial is to optimize and sustain the efficacy of PST for reducing pain in veterans with advanced knee OA and unrelieved pain by combining it with booster PST. Our secondary aims are to 1) improve physical performance in these individuals, and 2) ascertain the physical and psychological predictors of response to PST. In a randomized controlled clinical trial, 180 veterans (age 50 and older) with persistent knee pain who have x-ray evidence of advanced OA will be assigned to one of three intervention groups: 1) control PST once a week for 10 weeks (i.e., needle placement with brief stimulation of non-periosteal needles), 2) PST once a week for 10 weeks followed by tapering PST boosters over 6 months, or 3) PST once a week for 10 weeks followed by tapering control-PST boosters over 6 months. Prior to initiating the intervention, immediately after the last session, and 6 months later, the following parameters will be assessed: 1) pain severity (WOMAC), 3) physical performance (gait velocity, stair climb, repetitive chair rise, timed up and go), and 4) psychological function (mood, coping, self-efficacy). Monthly telephone calls will assess pain, interim illness and physical activity.

Study Design

Study Type:
Interventional
Actual Enrollment :
190 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
Efficacy of Periosteal Stimulation and Boosters for Advanced Knee OA Pain
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Sep 1, 2013
Actual Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: PST + PST boosters

PST once a week for 10 weeks, then tapering over 6 months

Other: Periosteal stimulation
Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.

Active Comparator: PST + control-PST boosters

PST once a week for 10 weeks, then control-PST tapering over 6 months

Other: Periosteal stimulation
Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.

Other: Control-Periosteal Stimulation
Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.

Placebo Comparator: Control-PST

control-PST for 10 weeks

Other: Control-Periosteal Stimulation
Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.

Outcome Measures

Primary Outcome Measures

  1. Pain (WOMAC) [9 months following baseline]

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • English speaking,

  • Knee pain on most days of the past 3 months that is more severe than pain in other parts of the lower body,

  • Advanced knee OA by x-ray,

  • age 50-89

Exclusion Criteria:
  • Non-ambulatory or severely impaired mobility (i.e., require the use of a walker),

  • Folstein MMSE < 24,

  • Severe uncorrected visual or hearing impairment,

  • Knee pain due to factors other than OA,

  • Large knee effusion,

  • History of corticosteroid or hyaluronic acid injection in the affected knee(s) during the preceding 3 months,

  • Acute or terminal illness,

  • Immune suppression,

  • Anticoagulation therapy,

  • Pacemaker,

  • Prior PST treatment

  • Active participation in other studies currently

  • Age >89

Contacts and Locations

Locations

Site City State Country Postal Code
1 Geriatric Research, Education, and Clinical Center Pittsburgh Pennsylvania United States 15206

Sponsors and Collaborators

  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: Debra K. Weiner, MD, Geriatric Research, Education, and Clinical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00865046
Other Study ID Numbers:
  • A6614-R
First Posted:
Mar 19, 2009
Last Update Posted:
Jan 26, 2015
Last Verified:
Jan 1, 2015
Keywords provided by US Department of Veterans Affairs
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Arm 1 Arm 2 Arm 3
Arm/Group Description PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
Period Title: Overall Study
STARTED 63 64 63
COMPLETED 57 59 62
NOT COMPLETED 6 5 1

Baseline Characteristics

Arm/Group Title Arm 1 Arm 2 Arm 3 Total
Arm/Group Description PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. Total of all reporting groups
Overall Participants 63 64 63 190
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
67.1
(8.9)
65.8
(8.7)
66.8
(10.4)
66.5
(9.3)
Sex: Female, Male (Count of Participants)
Female
8
12.7%
10
15.6%
11
17.5%
29
15.3%
Male
55
87.3%
54
84.4%
52
82.5%
161
84.7%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
2
3.2%
0
0%
0
0%
2
1.1%
Not Hispanic or Latino
61
96.8%
64
100%
63
100%
188
98.9%
Unknown or Not Reported
0
0%
0
0%
0
0%
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
0
0%
Asian
0
0%
0
0%
0
0%
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
0
0%
Black or African American
18
28.6%
22
34.4%
16
25.4%
56
29.5%
White
45
71.4%
42
65.6%
47
74.6%
134
70.5%
More than one race
0
0%
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
United States
63
100%
64
100%
63
100%
190
100%
WOMAC (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
9.0
(3.2)
9.9
(4.0)
10.6
(3.6)
9.8
(3.6)
Short Physical Performance Battery (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
6.1
(1.8)
6.1
(1.9)
6.2
(1.5)
6.1
(1.7)
Timed stair climb (seconds) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [seconds]
12.5
(4.7)
14.5
(7.8)
13.9
(7.3)
13.6
(6.6)
Timed Up and Go (seconds) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [seconds]
12.3
(3.4)
13.1
(3.8)
13.9
(6.9)
13.1
(4.7)
CES-D (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
11.7
(10.3)
14.7
(11.2)
12.3
(9.6)
12.9
(10.4)
Cognitive Strategies Questionnaire, catastrophizing scale (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
7.9
(7.8)
12.1
(9.7)
8.8
(9.2)
9.6
(8.9)
BMI (kg/m2) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [kg/m2]
31.6
(6.5)
33.1
(6.2)
32.5
(6.9)
32.4
(6.5)
Mean number of pain medications (medication) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [medication]
1.1
(1.0)
1.2
(0.9)
1.0
(0.9)
1.1
(0.9)
Mean number of opioids (opioids) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [opioids]
0.1
(0.3)
0.3
(0.6)
0.2
(0.4)
0.2
(0.4)
Duration of knee pain (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
5.7
(6.4)
6.2
(6.8)
7.2
(8.3)
6.4
(7.2)
Arthritis Self-Efficacy score, pain (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
64.3
(21.6)
59.5
(22.6)
63.9
(21.7)
62.6
(22)
Arthritis Self-Efficacy score, function (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
77.5
(17.0)
76.3
(16.9)
76.1
(16.4)
76.6
(16.8)
Arthritis Self-Efficacy score, other symptoms (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
70.5
(21.1)
65.9
(20.3)
68.6
(20.9)
68.3
(20.8)

Outcome Measures

1. Primary Outcome
Title Pain (WOMAC)
Description The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)
Time Frame 9 months following baseline

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Arm 1 Arm 2 Arm 3
Arm/Group Description PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
Measure Participants 57 59 62
Mean (Standard Error) [units on a scale]
6.1
(3.5)
6.6
(3.6)
7.9
(7.7)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Arm 1 Arm 2 Arm 3
Arm/Group Description PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
All Cause Mortality
Arm 1 Arm 2 Arm 3
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN) / (NaN)
Serious Adverse Events
Arm 1 Arm 2 Arm 3
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 3/63 (4.8%) 1/64 (1.6%) 1/63 (1.6%)
Cardiac disorders
Myocardial Infarction 1/63 (1.6%) 1 0/64 (0%) 0 0/63 (0%) 0
Gastrointestinal disorders
Bowel obstruction 1/63 (1.6%) 1 0/64 (0%) 0 0/63 (0%) 0
General disorders
Death 1/63 (1.6%) 1 0/64 (0%) 0 0/63 (0%) 0
Infections and infestations
abscess 0/63 (0%) 0 1/64 (1.6%) 1 0/63 (0%) 0
Respiratory, thoracic and mediastinal disorders
Dyspnea 0/63 (0%) 0 0/64 (0%) 0 1/63 (1.6%) 1
Other (Not Including Serious) Adverse Events
Arm 1 Arm 2 Arm 3
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 3/63 (4.8%) 0/64 (0%) 1/63 (1.6%)
General disorders
sweating 0/63 (0%) 0 0/64 (0%) 0 0/63 (0%) 0
Lightheaded 1/63 (1.6%) 1 0/64 (0%) 0 0/63 (0%) 0
Musculoskeletal and connective tissue disorders
Pain 1/63 (1.6%) 1 0/64 (0%) 0 1/63 (1.6%) 1
Skin and subcutaneous tissue disorders
Bruising 1/63 (1.6%) 1 0/64 (0%) 0 0/63 (0%) 0

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Debra K. Weiner
Organization VA Pittsburgh Healthcare System
Phone 412-360-2920
Email debra.weiner@va.gov
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00865046
Other Study ID Numbers:
  • A6614-R
First Posted:
Mar 19, 2009
Last Update Posted:
Jan 26, 2015
Last Verified:
Jan 1, 2015